Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00353704
Other study ID # 2005-003229-20
Secondary ID
Status Completed
Phase Phase 4
First received July 17, 2006
Last updated July 19, 2011
Start date November 2005
Est. completion date June 2010

Study information

Verified date July 2011
Source Asker & Baerum Hospital
Contact n/a
Is FDA regulated No
Health authority Norway: Norwegian Medicines Agency
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine whether the use of oral pregabalin 150 mg as premedication reduces the amount and degree of postoperative pain.

Furthermore the purpose of this study is to determine whether the use of oral pregabalin 150 mg as premedication reduces anxiety prior to anaesthesia in these patients.


Description:

The mechanism of development of postoperative pain is complex. Central and peripheral sensitization are playing an important role and this can lead to postoperative hypersensitization. Several studies have shown, that gabapentin can be effective to reduce sensitization and postoperative pain. Pregabalin (S-aminomethyl-5-methylhexaninacid) is a further development of gabapentin. Pregabalin has a fewer side-effects compared with gabapentin.

The purpose of this study is to compare the analgetic and anxiolytic effect of pregabalin and placebo used as premedication.

The hypothesis is that a single-dose pregabalin (150 mg postoperatively (p.o.)) gives significant better anxiolysis and analgesia than placebo.

The study is including patients undergoing surgery of the vertebral columna.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date June 2010
Est. primary completion date May 2009
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Clinical diagnosis of disc prolapse

- Age 18+

- ASA (American Association in Anesthesiology) I-III

- written consent

Exclusion Criteria:

- Age < 18

- ASA > III

- liver failure

- renal failure

- allergic reaction against gabapentin and/or pregabalin

- pregnancy

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Intervention

Drug:
pregabalin
capsule 150 mg x 1 per orally one hour before surgery
Placebo
One capsule of saccharose (placebo) was administered about one hour before surgery
morphine
All patients were equipped with a PCA (patient controlled analgesia) for 24 hours after surgery. The sum of morphine used was registered (milligram).

Locations

Country Name City State
Norway Asker and Baerum Hospital Rud

Sponsors (1)

Lead Sponsor Collaborator
Asker & Baerum Hospital

Country where clinical trial is conducted

Norway, 

References & Publications (3)

Dirks J, Fredensborg BB, Christensen D, Fomsgaard JS, Flyger H, Dahl JB. A randomized study of the effects of single-dose gabapentin versus placebo on postoperative pain and morphine consumption after mastectomy. Anesthesiology. 2002 Sep;97(3):560-4. — View Citation

Ménigaux C, Adam F, Guignard B, Sessler DI, Chauvin M. Preoperative gabapentin decreases anxiety and improves early functional recovery from knee surgery. Anesth Analg. 2005 May;100(5):1394-9, table of contents. — View Citation

Woolf CJ, Chong MS. Preemptive analgesia--treating postoperative pain by preventing the establishment of central sensitization. Anesth Analg. 1993 Aug;77(2):362-79. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Mean VAS Pain (Visual Analogue Scale)at Rest (0-100 mm) The visual analogue scale (VAS) was used for registration of the pain intensity at rest. The score ranges from 0-100, where 0 means no pain and 100 means maximal pain. Higher values represent a worse outcome. 120 minutes after surgery No
Secondary Morphine (Opioid) Consumption Cumulated Patients were equipped with a morphine PCA (patient controlled analgesia) for 24 hours after surgery. So they could administrate morphine intravenously by pressing a button. The sum of morphine was registered as " cumulated opioid consumption (milligram) 240 minutes No
See also
  Status Clinical Trial Phase
Completed NCT01615328 - Evaluation of Fusion Rate of Anterior Cervical Discectomy and Fusion (ACDF) Using Cervios ChronOs™ and Bonion™ Phase 4
Completed NCT02425514 - Evaluation of Bone Union Following Anterior Cervical Fusion Using a NovoMax™ N/A
Completed NCT00942227 - The Value of Traction in Treatment of Lumbar Radiculopathy Phase 3
Completed NCT00979108 - The Value of Traction in the Treatment of Cervical Radiculopathy Phase 3
Completed NCT00934284 - Effectiveness Study of Physical Therapy as an Adjunct to a Lumbar Therapeutic Selective Nerve Root Block Phase 2
Completed NCT00415220 - Manipulation or Microdiscectomy For Sciatica? A Prospective Randomized Controlled Trial. Phase 2
Terminated NCT02070484 - Human Amniotic Tissue-derived Allograft, NuCel, in Posteriolateral Lumbar Fusions for Degenerative Disc Disease N/A
Completed NCT00868335 - Cervical Spine; Movement Before and After Anterior Cervical Discectomy, With or Without a Cervical Disc Prosthesis N/A